Figure 1
Giemsa-stained touch prep of the patient's bone marrow at presentation, showing monocytoid appearance of the blasts.
TO THE EDITOR
A 39-year-old white man with a history of peptic ulcer disease presented with a 1 week history of malaise, anorexia, nausea, vomiting, fevers and progressive dyspnea. He had no history of exposure to toxins or radiation. He was afebrile, without hepatomegaly, splenomegaly, lymphadenopathy, nor gum hypertrophy. Radiogram showed bilateral pulmonary infiltrates. Initial hemoglobin was 11.1 gm/dl, platelet count 31 000/mm 3 , white blood count 74 000/mm 3 . The differential showed
Figure 2
Trypsin-Giemsa banded karyotype of a representative metaphase cell. 47,XY,+5,t(11;17)(q23;q12 The blasts were large with moderate amounts of light blue cytoplasm, prominent nucleoli, many with folded, irregularly contoured nuclei ( Figure 1 ). Bone marrow biopsy revealed replacement of normal hematopoietic tissue with blasts. Nearly all of the cells were strongly nonspecific esterase (NSE) positive, inhibited by fluoride. Weak chloracetate esterase reactivity was seen following fluoride inhibition of the NSE reaction. Flow cytometric immunophenotyping studies demonstrated HLA-DR positive, mostly myeloperoxidase negative myeloid cells which also were CD56-positive, but were CD34-negative (see Table 1 ). These results were interpreted as indicating acute monocytic leukemia, FAB M5.
Despite broad spectrum antibiotics, steroids, hydroxyurea and leu-kaphoresis, the patient's respiratory status continued to decline, and he expired on the fourth hospital day. Post-mortem examination revealed generalized pulmonary hemorrhage and congestion, consistent with adult respiratory distress syndrome. Cytogenetic studies revealed 47,XY,+5,t(11;17)(q23;q12) in 22 cells ( Figure 2) ; 47,XY, +5,t(11;17)(q23;q12),del(9)(q34) in five cells. The t(11;17)(q23;q12) deserves special attention, due to the involvement of two important breakpoints, 11q23 and 17q12, the site of MLL and the retinoic acid receptor ␣ (RAR␣), respectively.
Fluorescence in situ hybridization (FISH) was performed with probes for MLL and RAR␣. Because of the lack of commercial availability of a separate RAR␣ genomic probe, FISH was performed in two stages. First, hybridization was performed with probes for t(15;17) (PML orange/RAR␣ green (Vysis, Downers Grove, IL, USA)) to verify that the PML gene on 15q22 was not translocated in this patient. No PML-RAR␣ rearrangement was detected in 400 interphase nuclei nor 10 metaphase cells analyzed.
Next, hybridization was performed with a combination of digoxigenin-labeled (red) MLL DNA probe (Oncor, Gaithersburg, MD, USA) and the t(15;17) probe; juxtaposition of red with green would therefore indicate co-localization of MLL and RAR␣ loci. Eight of the patient's metaphase cells showed one C-group chromosome, presumably the normal chromosome 11 with a red signal; one C-group chromosome, presumably the abnormal chromosome 11 with a red signal and an adjacent green signal; two D-group chromosomes, presumably chromosomes 15, each with a red signal; one E-group chromosome, presumably the normal chromosome 17, with a green signal; and one shorter E-group chromosome, presumably the abnormal chromosome 17, with a red signal. Several cells showed a yellow signal, indicating close juxtaposition or fusion of the MLL and RAR␣ loci (Figure 3b ). Ten metaphase cells examined from a concurrent control showed only the expected signals on chromosomes 11, 15 and 17.
In summary, molecular cytogenetic analysis confirmed the presence of the t(11;17)(q23;q12) translocation and discounted the possibility of a cryptic PML-RAR␣ translocation. The MLL gene was split and partly translocated to the derivative chromosome 17. Simultaneously, the segment of the RAR␣ gene detected by the DNA probe was translocated to the derivative chromosome 11, to a site in close proximity to the remaining segment of the MLL gene at band 11q23.
Over 20 fusion partners have been identified for the MLL translocations. [1] [2] [3] [4] [5] All rearrangements cluster within MLL exons 5-11. 1, 6 In all reported MLL translocations, MLL is fused in the appropriate reading frame with its translocation partner to express a fusion protein with the MLL domain at the N-terminus. A unifying mechanism to explain the contribution of all the MLL fusion proteins in leukemogenesis is not available at present, but interestingly, several of the fusion partners are known to either directly or indirectly alter chromatin structure. [7] [8] [9] Though the FISH analysis of our patient indicates a reciprocal translocation of the MLL gene with a locus on 17q12, it is not possible for us to state unequivocally that the breakpoint at 17q12 falls within the RAR␣ locus. The Vysis RAR␣ probe hybridizes to a 400 kb region telomeric to RAR␣ exon 4. Thus, it could not distinguish between a translocation within the RAR␣ locus 5′ to intron 4 (such as occurs in t(15;17) that characterizes acute promyelocytic leukemia (APL)), or one centromeric to the RAR␣ locus entirely. Involvement of a locus centromeric to RAR␣ has once been reported in a patient with acute monocytic leukemia and t(11;17)(q23;q12-21) that did not involve the RAR␣ locus. 10 Unfortunately, insufficient material is available for further molecular analysis to determine whether the blasts of our patient expressed a MLL-RAR␣ fusion protein. However, it is not unreasonable to speculate that the breakpoint in our patient was within the RAR␣ locus, and that an MLL-RAR␣ fusion protein was expressed.
RAR␣ rearrangement has previously been identified exclusively in cases of APL (FAB M3). A putative MLL-RAR␣ fusion would share many characteristics of other MLL fusion proteins that produce 11q23 aggressive leukemias. Many of the fusion partners are transcriptional activator proteins, 5, 11 and similar to RAR␣, interact with co-activators capable of altering chromatin structure through histone acetylation. [12] [13] [14] Several of the fusion partners, such as CBP 7-9 and p300, 15 are themselves histone acetyl transferases (HAT). It has been proposed that recruitment of co-activator complexes that contain HAT activity might mediate a chromatin remodeling step critical to the biologic function of many MLL-fusions. 16 The C-terminus of liganded RAR␣ recruits the same HAT-containing co-activator complex.
13,17 A putative MLL-RAR␣ fusion protein would fit well with this paradigm. Fluorescence in situ hybridization. (a) Representative metaphase spread and nucleus after FISH with the MLL probe (from chromosome 11, labeled in red), PML probe (from chromosome 15, labeled in red), and the RAR␣ probe (from chromosome 17, labeled in green). Note the rearrangement juxtaposing the MLL and RAR␣ probes on the derivative chromosome 11. Also, note the derivative chromosome 17 lacking the RAR␣ signal, which was translocated to the der(11), and having gained the MLL signal, which was split and the distal segment translocated to the der (17) . The intact nucleus shows five red signals (one of which appears as a double dot) and two green signals. (b) Note the yellow signal, indicating close juxtaposition/fusion of the MLL and RAR␣ loci.
